The use of minoxidil in the treatment of male and female androgenetic alopecia: A story of more than 30 years

Mauro Barbareschi

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Even if minoxidil has been known for over 30 years as "hair growth stimulator" the precise mechanism of its action is not completely elucitated. Minoxidil shortens telogen, accelerates telogen-exogen phase and causes the premature entry of resting hair follicles into anagen phase. Moreover, minoxidil increases hair follicle size. A large part of hair treatment scientific literature confirms the efficacy of topically applied minoxidil in humans. In particular, patients treated with minoxidil showed a significant increase in "non vellus" hair count starting from baseline. Preparation of minoxidil requires molecule stability and solubility. Today are available on the market minoxidil-based formulations having low-concentration of propylene glycol to obtain preparations with a better cosmetical acceptance and dermatological safety. The body of evidences indicates that minoxidil still represent a milestone in the treatment of androgenetic alopecia and that its story is going on.

Original languageEnglish
Pages (from-to)102-106
Number of pages5
JournalGiornale Italiano di Dermatologia e Venereologia
Volume153
Issue number1
DOIs
Publication statusPublished - Feb 1 2018
Externally publishedYes

Fingerprint

Minoxidil
Alopecia
Hair
Hair Follicle
Therapeutics
Literature
Propylene Glycol
Solubility
Safety

Keywords

  • Alopecia
  • Minoxidil
  • Propylene glycol
  • Treatment outcome

ASJC Scopus subject areas

  • Dermatology

Cite this

The use of minoxidil in the treatment of male and female androgenetic alopecia : A story of more than 30 years. / Barbareschi, Mauro.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 153, No. 1, 01.02.2018, p. 102-106.

Research output: Contribution to journalReview article

@article{97a2794110e949169de314055df618c5,
title = "The use of minoxidil in the treatment of male and female androgenetic alopecia: A story of more than 30 years",
abstract = "Even if minoxidil has been known for over 30 years as {"}hair growth stimulator{"} the precise mechanism of its action is not completely elucitated. Minoxidil shortens telogen, accelerates telogen-exogen phase and causes the premature entry of resting hair follicles into anagen phase. Moreover, minoxidil increases hair follicle size. A large part of hair treatment scientific literature confirms the efficacy of topically applied minoxidil in humans. In particular, patients treated with minoxidil showed a significant increase in {"}non vellus{"} hair count starting from baseline. Preparation of minoxidil requires molecule stability and solubility. Today are available on the market minoxidil-based formulations having low-concentration of propylene glycol to obtain preparations with a better cosmetical acceptance and dermatological safety. The body of evidences indicates that minoxidil still represent a milestone in the treatment of androgenetic alopecia and that its story is going on.",
keywords = "Alopecia, Minoxidil, Propylene glycol, Treatment outcome",
author = "Mauro Barbareschi",
year = "2018",
month = "2",
day = "1",
doi = "10.23736/S0392-0488.17.05781-9",
language = "English",
volume = "153",
pages = "102--106",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - The use of minoxidil in the treatment of male and female androgenetic alopecia

T2 - A story of more than 30 years

AU - Barbareschi, Mauro

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Even if minoxidil has been known for over 30 years as "hair growth stimulator" the precise mechanism of its action is not completely elucitated. Minoxidil shortens telogen, accelerates telogen-exogen phase and causes the premature entry of resting hair follicles into anagen phase. Moreover, minoxidil increases hair follicle size. A large part of hair treatment scientific literature confirms the efficacy of topically applied minoxidil in humans. In particular, patients treated with minoxidil showed a significant increase in "non vellus" hair count starting from baseline. Preparation of minoxidil requires molecule stability and solubility. Today are available on the market minoxidil-based formulations having low-concentration of propylene glycol to obtain preparations with a better cosmetical acceptance and dermatological safety. The body of evidences indicates that minoxidil still represent a milestone in the treatment of androgenetic alopecia and that its story is going on.

AB - Even if minoxidil has been known for over 30 years as "hair growth stimulator" the precise mechanism of its action is not completely elucitated. Minoxidil shortens telogen, accelerates telogen-exogen phase and causes the premature entry of resting hair follicles into anagen phase. Moreover, minoxidil increases hair follicle size. A large part of hair treatment scientific literature confirms the efficacy of topically applied minoxidil in humans. In particular, patients treated with minoxidil showed a significant increase in "non vellus" hair count starting from baseline. Preparation of minoxidil requires molecule stability and solubility. Today are available on the market minoxidil-based formulations having low-concentration of propylene glycol to obtain preparations with a better cosmetical acceptance and dermatological safety. The body of evidences indicates that minoxidil still represent a milestone in the treatment of androgenetic alopecia and that its story is going on.

KW - Alopecia

KW - Minoxidil

KW - Propylene glycol

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=85040824812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040824812&partnerID=8YFLogxK

U2 - 10.23736/S0392-0488.17.05781-9

DO - 10.23736/S0392-0488.17.05781-9

M3 - Review article

AN - SCOPUS:85040824812

VL - 153

SP - 102

EP - 106

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 1

ER -